BioHarvest Sciences Inc.
CNVCF
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -8.14M | -10.33M | -9.86M | -11.24M | -10.18M |
| Total Depreciation and Amortization | 816.00K | 793.00K | 774.00K | 712.00K | 658.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.42M | 8.00K | -3.00K | 1.59M | 541.00K |
| Change in Net Operating Assets | 708.00K | -4.00K | 694.00K | -308.00K | -39.00K |
| Cash from Operations | -8.03M | -9.54M | -8.39M | -9.24M | -9.02M |
| Capital Expenditure | -1.45M | -1.29M | -1.24M | -1.26M | -1.35M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.45M | -1.29M | -1.24M | -1.26M | -1.35M |
| Total Debt Issued | 8.77M | 10.68M | 8.36M | 7.66M | 5.31M |
| Total Debt Repaid | -357.00K | -346.00K | -339.00K | -359.00K | -379.00K |
| Issuance of Common Stock | 404.00K | 1.13M | 731.00K | 877.00K | 926.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -38.00K | -38.00K | -38.00K | -38.00K | -- |
| Cash from Financing | 8.78M | 11.43M | 8.71M | 8.14M | 5.85M |
| Foreign Exchange rate Adjustments | -13.00K | -12.00K | -44.00K | -22.00K | -24.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -713.00K | 598.00K | -966.00K | -2.38M | -4.54M |
